Table 60Clinical review protocol summary for the review on the prevention of mental health problems

ComponentDescription
Review questionIn people (children, young people and adults) with learning disabilities, do pharmacological interventions aimed at preventing mental health problems produce benefits that outweigh possible harms when compared with an alternative approach? (RQ2.4)
PopulationPeople (children, young people and adults) with learning disabilities.
Intervention(s)Any licensed pharmacological interventions
Comparison
  • Treatment as usual
  • No treatment, placebo
  • Any of the other interventions (that is, head-to-head trials)
Critical outcomes
  • Mental health
  • Community participation and meaningful occupation
  • Problem behaviours
  • Quality of life/service user and carer satisfaction/experience of care
Study designSystematic reviews, RCTs, controlled before and after studies and cohort studies.

From: 6, Pharmacological interventions

Cover of Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management
Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management.
NICE Guideline, No. 54.
National Guideline Alliance (UK).
Copyright © National Institute for Health and Care Excellence 2016.

All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.